No products in the cart.
CASP Certification Program
Module 14: Health Economics & Cost Management
Mastering the Language of Value: Pharmacoeconomics for the Advanced Practitioner.
Beyond the Copay: Understanding the True Cost of Care
As pharmacists on the front lines, you grapple daily with the immediate financial realities of medication access. You witness patient struggles with high copays, navigate the frustrations of prior authorizations, and search for cost-saving alternatives. You understand the price of medications at the point of sale.
This module elevates that understanding from the transactional level of price to the strategic level of cost and value within the broader healthcare system. To truly function as an advanced practitioner and a leader in specialty pharmacy, you must become fluent in the language of health economics. You need to move beyond asking “How much does this drug cost the patient today?” to asking “What is the total cost impact of this therapy on the health system, and does its clinical benefit justify that cost?”
We will delve into the core principles of pharmacoeconomics, exploring how payers and health systems evaluate the financial implications of medication use across entire populations. You will learn to analyze budget impact models, interpret cost-effectiveness studies, understand the rationale behind utilization management tools like step-therapy, and contribute meaningfully to formulary decisions. This knowledge is essential not only for optimizing patient care within financial constraints but also for articulating the economic value proposition of advanced pharmacy services and securing sustainable reimbursement models. Mastering health economics transforms you from a medication dispenser into a strategic cost manager and value creator.
Navigating the Economic Landscape
This module provides the tools to analyze and influence the economic dimensions of medication management.
Budget Impact and Pharmacoeconomic Principles
Laying the foundation: Understanding core concepts like budget impact models (BIMs), types of pharmacoeconomic analyses (CMA, CEA, CBA, CUA), and perspective in economic evaluations.
Cost-Effectiveness and QALY Assessments
A deep dive into cost-effectiveness analysis (CEA) and cost-utility analysis (CUA), interpreting incremental cost-effectiveness ratios (ICERs), and understanding the role of Quality-Adjusted Life Years (QALYs) in value assessment.
Step-Therapy and Utilization Review Protocols
Examining common payer strategies for managing drug utilization, understanding the clinical and economic rationale behind step-edits, prior authorizations (PAs), and quantity limits (QLs), and the pharmacist’s role in navigating them.
Formulary Strategy and Payer Collaboration
Understanding the formulary decision-making process (P&T Committees), the impact of tiering and preferred drug lists, and how pharmacists can collaborate with payers on formulary design and management.
ROI and Financial Forecasting for Specialty Lines
Applying economic principles to practice: Developing Return on Investment (ROI) models for clinical pharmacy services, forecasting the financial impact of new specialty drug lines, and making the business case for pharmacy initiatives.
